metamorworks/iStock via Getty Images Evolent Health ( NYSE: EVH ) to acquire certain assets of Machinify and the exclusive, perpetual and royalty-free license of Machinify Auth, a platform that leverages latest advances in artificial intelligence to increase the clinical quality, speed and consistency of the clinical reviews for all specialty conditions, it said on Tuesday. Evolent plans to integrate the Machinify Auth team, software applications and AI capabilities into its leading platform, it said. Evolent Health ( EVH ) and Machinify will also enter into a multi-year services agreement to support the success of the acquisition.
The solution to be acquired, Machinify Auth, functions as a co-pilot for nurses and doctors and brings a proven track record of reducing clinician workforce time by an average of 55% for complex, manual reviews for a large national payer customer and its provider network, Evolent Health ( EVH ) said. "The acquisition of Machinify Auth will create an incredibly powerful opportunity for Evolent and for our client base of approximately 70 health plans," stated Seth Blackley, Co-Founder and Chief Executive Officer of Evolent. Source: Press Release More on Evolent Health Evolent Health: Recent Pullback, A Buying Opportunity Or Not? (Rating Downgrade) Evolent Health, Inc.
(EVH) Q1 2024 Earnings Call Transcript Engaged Capital's Q1 moves: adds Envestnet, trims Shake Shack, others Evolent down 9% despite quarterly beats on Q2 EBITDA guidance Seeking Alpha�.